The head of a major US auto parts supplier, following its acquisition of Britain's GKN Automotive, cautions that European nations must implement protective policies or face severe job losses as affordable Chinese electric vehicles reshape the market.
The crypto miner turned infrastructure player has acquired two high-capacity sites in Kentucky and Maryland, boosting its total planned capacity to 2.8 gigawatts as it capitalizes on the soaring demand for compute and power.
Bill Stevenson, the 77-year-old former spouse of Dr. Jill Biden, has been formally charged with first-degree murder in the death of his wife Linda, following a grand jury indictment. The case stems from a late December domestic incident at their New Castle County residence.
ASML Holding's share price has soared 74% over the past year, fueled by relentless demand for its advanced chipmaking equipment. As the stock trades near record highs, investors are grappling with a critical question: has the market gotten ahead of itself, or is this just the beginning?
Eaton Corporation posts solid fourth-quarter results but tempers 2026 earnings expectations, even as it deepens its strategic partnership with Flexnode to capitalize on the booming AI data center infrastructure market.
Moderna forges a key partnership with Recordati to advance a therapy for propionic acidemia, while appointing a new Chief Development Officer as part of its strategic expansion beyond its COVID-19 vaccine roots.
Palantir Technologies' shares surged nearly 7% following a blockbuster earnings report, fueled by a 66% jump in U.S. government revenue. The data analytics firm, a key Pentagon and intelligence community contractor, is riding a wave of increased defense spending, though its high valuation and controversial ICE surveillance work draw mixed reactions from investors and analysts.
Elon Musk has announced the merger of SpaceX and his artificial intelligence firm xAI, creating a $1.25 trillion private tech and aerospace giant. The move intensifies focus on whether Tesla will be the next piece to join Musk's consolidating empire.
Pfizer reported a quarterly loss driven by significant asset impairments and declining COVID-19 product sales, sending shares lower. The pharmaceutical giant reaffirmed its 2026 financial targets but signaled no share buybacks as it prioritizes debt reduction and a costly R&D pipeline aimed at replacing lost patent revenues.
The German federal government has acquired a 25.1% stake in transmission system operator TenneT Germany for €3.3 billion, marking a significant step in securing funding for the massive grid expansion required by the nation's shift to renewable energy.
Despite underperforming the broader market over the past year, Weyerhaeuser (WY) retains a 'Moderate Buy' consensus from Wall Street. Analysts point to its strategic biocarbon venture and solid earnings history as catalysts, even as share price targets signal significant potential upside.
AMETEK reported robust fourth-quarter and full-year 2025 results, setting new records across key financial metrics. The diversified technology manufacturer highlighted double-digit sales and order growth, significant margin expansion, and a record backlog. The company also announced the acquisition of LKC Technologies and provided an optimistic outlook for 2026, underpinned by a disciplined capital deployment strategy and a focus on high-value niche markets.
The German state has acquired a 25.1% stake in the German subsidiary of Dutch grid operator TenneT for €3.3 billion, a move aimed at securing funding for critical infrastructure upgrades and reinforcing national energy resilience.
SolarEdge Technologies has initiated exports of its U.S.-manufactured residential inverters to key European markets, marking a strategic pivot to leverage domestic production for global growth. The move, coupled with a new 'single SKU' product design, aims to streamline operations and improve margins as the company navigates a competitive landscape.
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing expansion for its injectable weight loss therapies, alongside forging two new research collaborations targeting hearing loss and autoimmune diseases, as its stock continues a meteoric rise.
New data reveals companies embracing structured flexibility are growing significantly faster and attracting deeper talent pools than their office-mandate rivals, reshaping the post-pandemic competitive landscape.
As clinical-stage biotech Alumis sees its stock price skyrocket on optimism for its autoimmune disease pipeline, one investment fund has made a contrarian move, selling its entire position just before a major rally.
BellRing Brands reports a solid Q1 2026, beating expectations but narrows full-year sales guidance amid heightened promotional activity from insurgent brands in the protein shake market. CEO Darcy Horn Davenport announces her retirement, marking the end of a 17-year tenure that saw the company grow from $20 million to a $2.3 billion global business.
Specialty materials leader ATI reports robust Q4 and full-year 2025 results, exceeding guidance on strong demand for proprietary aerospace alloys and defense systems. With a new CFO at the helm, the company projects 16% EBITDA growth for 2026, fueled by long-term agreements and strategic capacity investments.
As markets recalibrate amid shifting Fed expectations, income-focused strategies gain prominence. We analyze two REITs with standout 8%+ yields and 'Strong Buy' ratings from Wall Street, examining their resilience and income-generating potential.
